Infectious diseases and therapy

Keyphrases

Publications

volume 13, number 8, 2024

Hardik Chandasana, Sven C van Dijkman, Rashmi Mehta, Mark Bush, Helena Rabie, Patricia Flynn, Tim R Cressey, Edward P Acosta, Kristina M Brooks, null null
Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1. Infectious diseases and therapy 13 (8) (2024)
Kozo Morimoto, Jack R Gallagher, Dirk Wagner, David E Griffith, Jakko van Ingen
Real-World Patients' Diagnosis-to-Treatment Journey with Nontuberculous Mycobacterial Pulmonary Disease: A Cross-Sectional Survey. Infectious diseases and therapy 13 (8) (2024)
Charles Nuttens, Juliette Moyersoen, Daniel Curcio, Zuleika Aponte-Torres, Marc Baay, Hilde Vroling, Bradford D Gessner, Elizabeth Begier
Differences Between RSV A and RSV B Subgroups and Implications for Pharmaceutical Preventive Measures. Infectious diseases and therapy 13 (8) (2024)
Robert Buynak, Kevin Cannon, David DeAtkine, John Kirby, Lisa Usdan, Amit B Bhavsar, Catherine Gérard, Anastasia Kuznetsova, Amulya Jayadev, Hiwot Amare, Sofia Valenciano, Nadia Meyer
Randomized, Open-Label Phase 3 Study Evaluating Immunogenicity, Safety, and Reactogenicity of RSVPreF3 OA Coadministered with FLU-QIV-HD in Adults Aged ≥ 65. Infectious diseases and therapy 13 (8) (2024)
Munirah S Aleyiydi, Noura M Alshiban, Areej M Alajmi, Nada F Alosaimi, Maryam Alotaibi, Majed S Nassar, Nada K Alhumaid, Thamer A Almangour, Ziad A Memish, Abdulwahab Z Binjomah, Saeed M Algarni, Ahmed Al-Jedai, Abdulaziz S Almutairi, Atef Shibl, Essam A Tawfik
Epidemiology of Viral Infectious Diseases Reported in Saudi Arabia. Infectious diseases and therapy 13 (8) (2024)
Takahiro Takazono, Satoki Fujita, Takuji Komeda, Shogo Miyazawa, Yuki Yoshida, Yoshitake Kitanishi, Masahiro Kinoshita, Satoshi Kojima, Huilian Shen, Takeki Uehara, Naoki Hosogaya, Naoki Iwanaga, Hiroshi Mukae
Real-World Effectiveness of Ensitrelvir in Reducing Severe Outcomes in Outpatients at High Risk for COVID-19. Infectious diseases and therapy 13 (8) (2024)
Javier Díez-Domingo, Róbert Simkó, Giancarlo Icardi, Chan Poh Chong, Céline Zocchetti, Olga Syrkina, Siham Bchir, Isabelle Bertrand-Gerentes
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix in Healthy Adolescents: A Randomized Phase IIIb Multicenter Study. Infectious diseases and therapy 13 (8) (2024)
Abdulwhab Shremo Msdi, Jacinda C Abdul-Mutakabbir, Karen K Tan
Characterizing Day 1 Area Under the Curve Following Vancomycin Loading Dose Administration in Adult Hospitalized Patients Using Non-Trapezoidal Linear Pharmacokinetic Equations: A Retrospective Observational Study. Infectious diseases and therapy 13 (8) (2024)
Stefan Michael Scholz, Kristina Dobrindt, Jennifer Tufts, Sarah Adams, Parinaz Ghaswalla, Bernhard Ultsch, Jens Gottlieb
The Burden of Respiratory Syncytial Virus (RSV) in Germany: A Comprehensive Data Analysis Suggests Underdetection of Hospitalisations and Deaths in Adults 60 Years and Older. Infectious diseases and therapy 13 (8) (2024)
Hardik Chandasana, Sven C van Dijkman, Rashmi Mehta, Mark Bush, Helena Rabie, Patricia Flynn, Tim R Cressey, Edward P Acosta, Kristina M Brooks, null null
Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1. Infectious diseases and therapy 13 (8) (2024)
Tianyu Sun, Linwei Li, Katherine E Mues, Mihaela V Georgieva, Brenna Kirk, James A Mansi, Nicolas Van de Velde, Ekkehard C Beck
Real-World Effectiveness of a Third Dose of mRNA-1273 Versus BNT162b2 on Inpatient and Medically Attended COVID-19 Among Immunocompromised US Adults. Infectious diseases and therapy 13 (8) (2024)
Kate Penrose, Avantika Srivastava, Yanhan Shen, McKaylee M Robertson, Sarah G Kulkarni, Kristen E Allen, Thomas M Porter, Laura Puzniak, John M McLaughlin, Denis Nash
Perceived Risk for Severe COVID-19 and Oral Antiviral Use Among Antiviral-Eligible US Adults. Infectious diseases and therapy 13 (8) (2024)
Charles Nuttens, Juliette Moyersoen, Daniel Curcio, Zuleika Aponte-Torres, Marc Baay, Hilde Vroling, Bradford D Gessner, Elizabeth Begier
Differences Between RSV A and RSV B Subgroups and Implications for Pharmaceutical Preventive Measures. Infectious diseases and therapy 13 (8) (2024)
Robert Buynak, Kevin Cannon, David DeAtkine, John Kirby, Lisa Usdan, Amit B Bhavsar, Catherine Gérard, Anastasia Kuznetsova, Amulya Jayadev, Hiwot Amare, Sofia Valenciano, Nadia Meyer
Randomized, Open-Label Phase 3 Study Evaluating Immunogenicity, Safety, and Reactogenicity of RSVPreF3 OA Coadministered with FLU-QIV-HD in Adults Aged ≥ 65. Infectious diseases and therapy 13 (8) (2024)
Munirah S Aleyiydi, Noura M Alshiban, Areej M Alajmi, Nada F Alosaimi, Maryam Alotaibi, Majed S Nassar, Nada K Alhumaid, Thamer A Almangour, Ziad A Memish, Abdulwahab Z Binjomah, Saeed M Algarni, Ahmed Al-Jedai, Abdulaziz S Almutairi, Atef Shibl, Essam A Tawfik
Epidemiology of Viral Infectious Diseases Reported in Saudi Arabia. Infectious diseases and therapy 13 (8) (2024)

volume 13, number 9, 2024

Marianna Mitratza, Malak Elsobky, Caihua Liang, Robin Bruyndonckx, Aleksandra Polkowska-Kramek, Worku Biyadgie Ewnetu, Pimnara Peerawaranun, Thao Mai Phuong Tran, Charles Nuttens, Ana Gabriela Grajales, Sazini Nzula, Bradford D Gessner, Elizabeth Begier
Estimated Incidence of Hospitalizations Attributable to RSV Infection Among Adults in Ontario, Canada, Between 2013 and 2019. Infectious diseases and therapy 13 (9) (2024)
Helen Graf, Caroline Gräfe, Mathias Bruegel, Felix L Happich, Vassilissa Wustrow, Aljoscha Wegener, Wolfgang Wilfert, Michael Zoller, Uwe Liebchen, Michael Paal, Christina Scharf
Extracorporeal Elimination of Pro- and Anti-inflammatory Modulators by the Cytokine Adsorber CytoSorb ® in Patients with Hyperinflammation: A Prospective Study. Infectious diseases and therapy 13 (9) (2024)
Hengxin Peng, Wenjun Zhang, Yanqing Lin, Huiming Li, Suofu Qin
Safety, Tolerability, and Pharmacokinetics of Nebulized GB05-Human IFNα1b Inhalation Solution: A Randomized, Placebo-Controlled, Dose-Escalation Phase I Study in Healthy Chinese Adult Volunteers. Infectious diseases and therapy 13 (9) (2024)
Ranjeet S Bhamber, Brian Sullivan, Léo Gorman, Winnie W Y Lee, Matthew B Avison, Andrew W Dowsey, Philip B Williams
A Bayesian Model Based on Local Phenotypic Resistance Data to Inform Empiric Antibiotic Escalation Decisions. Infectious diseases and therapy 13 (9) (2024)
Abby E Rudolph, Farid L Khan, Tanya G Singh, Srinivas Rao Valluri, Laura A Puzniak, John M McLaughlin
Proportion of Patients in the United States Who Fill Their Nirmatrelvir/Ritonavir Prescriptions. Infectious diseases and therapy 13 (9) (2024)
Svenn Alexander Kommandantvold, Shih-Chen Chang, Andy Surinach, Vincent Yau, Jennie H Best, Hassan Zaraket, Hao Zhou, Jeff Frimpter, Marie-Helene Blanchet Zumofen
Cost-Effectiveness of Baloxavir Marboxil Versus Oseltamivir or no Treatment for the Management of Influenza in the United States. Infectious diseases and therapy 13 (9) (2024)
Mariana Haeberer, Martin Mengel, Rong Fan, Marina Toquero-Asensio, Alejandro Martin-Toribio, Qing Liu, Yongzheng He, Sonal Uppal, Silvia Rojo-Rello, Marta Domínguez-Gil, Cristina Hernán-García, Virginia Fernández-Espinilla, Caihua Liang, Elizabeth Begier, Javier Castrodeza Sanz, José M Eiros, Ivan Sanz-Muñoz
RSV Risk Profile in Hospitalized Adults and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010-2022. Infectious diseases and therapy 13 (9) (2024)
Svenn Alexander Kommandantvold, Shih-Chen Chang, Andy Surinach, Vincent Yau, Jennie H Best, Hassan Zaraket, Hao Zhou, Jeff Frimpter, Marie-Helene Blanchet Zumofen
Cost-Effectiveness of Baloxavir Marboxil Versus Oseltamivir or no Treatment for the Management of Influenza in the United States. Infectious diseases and therapy 13 (9) (2024)
Helen Graf, Caroline Gräfe, Mathias Bruegel, Felix L Happich, Vassilissa Wustrow, Aljoscha Wegener, Wolfgang Wilfert, Michael Zoller, Uwe Liebchen, Michael Paal, Christina Scharf
Extracorporeal Elimination of Pro- and Anti-inflammatory Modulators by the Cytokine Adsorber CytoSorb ® in Patients with Hyperinflammation: A Prospective Study. Infectious diseases and therapy 13 (9) (2024)
Svenn Alexander Kommandantvold, Shih-Chen Chang, Andy Surinach, Vincent Yau, Jennie H Best, Hassan Zaraket, Hao Zhou, Jeff Frimpter, Marie-Helene Blanchet Zumofen
Cost-Effectiveness of Baloxavir Marboxil Versus Oseltamivir or no Treatment for the Management of Influenza in the United States. Infectious diseases and therapy 13 (9) (2024)
Johnna E Perdrizet, Mark H Rozenbaum, Matthew J Heffler
Pediatric Pneumococcal Conjugate Vaccine and Dosing Schedule Perceptions Among Health Care Providers and Caregivers in Germany, France, Spain, and Greece. Infectious diseases and therapy 13 (9) (2024)
Mariana Haeberer, Martin Mengel, Rong Fan, Marina Toquero-Asensio, Alejandro Martin-Toribio, Qing Liu, Yongzheng He, Sonal Uppal, Silvia Rojo-Rello, Marta Domínguez-Gil, Cristina Hernán-García, Virginia Fernández-Espinilla, Caihua Liang, Elizabeth Begier, Javier Castrodeza Sanz, José M Eiros, Ivan Sanz-Muñoz
RSV Risk Profile in Hospitalized Adults and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010-2022. Infectious diseases and therapy 13 (9) (2024)
Shahina Begum, Eliazar Sabater Cabrera, Oscar Herrera Restrepo, Cindy Burman, Woo-Yun Sohn, Elise J Kuylen, Hiral Anil Shah, Zeki Kocaata
Quantifying Stated Preferences for Meningococcal Vaccines Among Adolescents/Young Adults and Parents of Adolescents in the United States: A Discrete Choice Experiment. Infectious diseases and therapy 13 (9) (2024)
Daniele Roberto Giacobbe, Laura Labate, Chiara Russo Artimagnella, Cristina Marelli, Alessio Signori, Vincenzo Di Pilato, Chiara Aldieri, Alessandra Bandera, Federica Briano, Bruno Cacopardo, Alessandra Calabresi, Federico Capra Marzani, Anna Carretta, Annamaria Cattelan, Luca Ceccarelli, Giovanni Cenderello, Silvia Corcione, Andrea Cortegiani, Rosario Cultrera, Francesco Giuseppe De Rosa, Valerio Del Bono, Filippo Del Puente, Chiara Fanelli, Fiorenza Fava, Daniela Francisci, Nicholas Geremia, Lucia Graziani, Andrea Lombardi, Angela Raffaella Losito, Ivana Maida, Andrea Marino, Maria Mazzitelli, Marco Merli, Roberta Monardo, Alessandra Mularoni, Chiara Oltolini, Carlo Pallotto, Emanuele Pontali, Francesca Raffaelli, Matteo Rinaldi, Marco Ripa, Teresa Antonia Santantonio, Francesco Saverio Serino, Michele Spinicci, Carlo Torti, Enrico Maria Trecarichi, Mario Tumbarello, Malgorzata Mikulska, Mauro Giacomini, Anna Marchese, Antonio Vena, Matteo Bassetti, null null
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study. Infectious diseases and therapy 13 (9) (2024)
Ranjeet S Bhamber, Brian Sullivan, Léo Gorman, Winnie W Y Lee, Matthew B Avison, Andrew W Dowsey, Philip B Williams
A Bayesian Model Based on Local Phenotypic Resistance Data to Inform Empiric Antibiotic Escalation Decisions. Infectious diseases and therapy 13 (9) (2024)
Mariana Haeberer, Martin Mengel, Rong Fan, Marina Toquero-Asensio, Alejandro Martin-Toribio, Qing Liu, Yongzheng He, Sonal Uppal, Silvia Rojo-Rello, Marta Domínguez-Gil, Cristina Hernán-García, Virginia Fernández-Espinilla, Caihua Liang, Elizabeth Begier, Javier Castrodeza Sanz, José M Eiros, Ivan Sanz-Muñoz
RSV Risk Profile in Hospitalized Adults and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010-2022. Infectious diseases and therapy 13 (9) (2024)
Marianna Mitratza, Malak Elsobky, Caihua Liang, Robin Bruyndonckx, Aleksandra Polkowska-Kramek, Worku Biyadgie Ewnetu, Pimnara Peerawaranun, Thao Mai Phuong Tran, Charles Nuttens, Ana Gabriela Grajales, Sazini Nzula, Bradford D Gessner, Elizabeth Begier
Estimated Incidence of Hospitalizations Attributable to RSV Infection Among Adults in Ontario, Canada, Between 2013 and 2019. Infectious diseases and therapy 13 (9) (2024)
Kathryn Hoffmann, Michael Stingl, Liam O'Mahony, Eva Untersmayr
A Practical Approach to Tailor the Term Long COVID for Diagnostics, Therapy and Epidemiological Research for Improved Long COVID Patient Care. Infectious diseases and therapy 13 (9) (2024)
Abby E Rudolph, Farid L Khan, Tanya G Singh, Srinivas Rao Valluri, Laura A Puzniak, John M McLaughlin
Proportion of Patients in the United States Who Fill Their Nirmatrelvir/Ritonavir Prescriptions. Infectious diseases and therapy 13 (9) (2024)
Daniele Roberto Giacobbe, Laura Labate, Chiara Russo Artimagnella, Cristina Marelli, Alessio Signori, Vincenzo Di Pilato, Chiara Aldieri, Alessandra Bandera, Federica Briano, Bruno Cacopardo, Alessandra Calabresi, Federico Capra Marzani, Anna Carretta, Annamaria Cattelan, Luca Ceccarelli, Giovanni Cenderello, Silvia Corcione, Andrea Cortegiani, Rosario Cultrera, Francesco Giuseppe De Rosa, Valerio Del Bono, Filippo Del Puente, Chiara Fanelli, Fiorenza Fava, Daniela Francisci, Nicholas Geremia, Lucia Graziani, Andrea Lombardi, Angela Raffaella Losito, Ivana Maida, Andrea Marino, Maria Mazzitelli, Marco Merli, Roberta Monardo, Alessandra Mularoni, Chiara Oltolini, Carlo Pallotto, Emanuele Pontali, Francesca Raffaelli, Matteo Rinaldi, Marco Ripa, Teresa Antonia Santantonio, Francesco Saverio Serino, Michele Spinicci, Carlo Torti, Enrico Maria Trecarichi, Mario Tumbarello, Malgorzata Mikulska, Mauro Giacomini, Anna Marchese, Antonio Vena, Matteo Bassetti, null null
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study. Infectious diseases and therapy 13 (9) (2024)
Mariana Haeberer, Martin Mengel, Rong Fan, Marina Toquero-Asensio, Alejandro Martin-Toribio, Qing Liu, Yongzheng He, Sonal Uppal, Silvia Rojo-Rello, Marta Domínguez-Gil, Cristina Hernán-García, Virginia Fernández-Espinilla, Caihua Liang, Elizabeth Begier, Javier Castrodeza Sanz, José M Eiros, Ivan Sanz-Muñoz
RSV Risk Profile in Hospitalized Adults and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010-2022. Infectious diseases and therapy 13 (9) (2024)
Kathryn Hoffmann, Michael Stingl, Liam O'Mahony, Eva Untersmayr
A Practical Approach to Tailor the Term Long COVID for Diagnostics, Therapy and Epidemiological Research for Improved Long COVID Patient Care. Infectious diseases and therapy 13 (9) (2024)
Shahina Begum, Eliazar Sabater Cabrera, Oscar Herrera Restrepo, Cindy Burman, Woo-Yun Sohn, Elise J Kuylen, Hiral Anil Shah, Zeki Kocaata
Quantifying Stated Preferences for Meningococcal Vaccines Among Adolescents/Young Adults and Parents of Adolescents in the United States: A Discrete Choice Experiment. Infectious diseases and therapy 13 (9) (2024)
Shahina Begum, Eliazar Sabater Cabrera, Oscar Herrera Restrepo, Cindy Burman, Woo-Yun Sohn, Elise J Kuylen, Hiral Anil Shah, Zeki Kocaata
Quantifying Stated Preferences for Meningococcal Vaccines Among Adolescents/Young Adults and Parents of Adolescents in the United States: A Discrete Choice Experiment. Infectious diseases and therapy 13 (9) (2024)
Johnna E Perdrizet, Mark H Rozenbaum, Matthew J Heffler
Pediatric Pneumococcal Conjugate Vaccine and Dosing Schedule Perceptions Among Health Care Providers and Caregivers in Germany, France, Spain, and Greece. Infectious diseases and therapy 13 (9) (2024)
Hengxin Peng, Wenjun Zhang, Yanqing Lin, Huiming Li, Suofu Qin
Safety, Tolerability, and Pharmacokinetics of Nebulized GB05-Human IFNα1b Inhalation Solution: A Randomized, Placebo-Controlled, Dose-Escalation Phase I Study in Healthy Chinese Adult Volunteers. Infectious diseases and therapy 13 (9) (2024)
Marianna Mitratza, Malak Elsobky, Caihua Liang, Robin Bruyndonckx, Aleksandra Polkowska-Kramek, Worku Biyadgie Ewnetu, Pimnara Peerawaranun, Thao Mai Phuong Tran, Charles Nuttens, Ana Gabriela Grajales, Sazini Nzula, Bradford D Gessner, Elizabeth Begier
Estimated Incidence of Hospitalizations Attributable to RSV Infection Among Adults in Ontario, Canada, Between 2013 and 2019. Infectious diseases and therapy 13 (9) (2024)
Abby E Rudolph, Farid L Khan, Tanya G Singh, Srinivas Rao Valluri, Laura A Puzniak, John M McLaughlin
Proportion of Patients in the United States Who Fill Their Nirmatrelvir/Ritonavir Prescriptions. Infectious diseases and therapy 13 (9) (2024)
Mariana Haeberer, Martin Mengel, Rong Fan, Marina Toquero-Asensio, Alejandro Martin-Toribio, Qing Liu, Yongzheng He, Sonal Uppal, Silvia Rojo-Rello, Marta Domínguez-Gil, Cristina Hernán-García, Virginia Fernández-Espinilla, Caihua Liang, Elizabeth Begier, Javier Castrodeza Sanz, José M Eiros, Ivan Sanz-Muñoz
RSV Risk Profile in Hospitalized Adults and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010-2022. Infectious diseases and therapy 13 (9) (2024)
Kathryn Hoffmann, Michael Stingl, Liam O'Mahony, Eva Untersmayr
A Practical Approach to Tailor the Term Long COVID for Diagnostics, Therapy and Epidemiological Research for Improved Long COVID Patient Care. Infectious diseases and therapy 13 (9) (2024)
Helen Graf, Caroline Gräfe, Mathias Bruegel, Felix L Happich, Vassilissa Wustrow, Aljoscha Wegener, Wolfgang Wilfert, Michael Zoller, Uwe Liebchen, Michael Paal, Christina Scharf
Extracorporeal Elimination of Pro- and Anti-inflammatory Modulators by the Cytokine Adsorber CytoSorb ® in Patients with Hyperinflammation: A Prospective Study. Infectious diseases and therapy 13 (9) (2024)
Johnna E Perdrizet, Mark H Rozenbaum, Matthew J Heffler
Pediatric Pneumococcal Conjugate Vaccine and Dosing Schedule Perceptions Among Health Care Providers and Caregivers in Germany, France, Spain, and Greece. Infectious diseases and therapy 13 (9) (2024)
Hengxin Peng, Wenjun Zhang, Yanqing Lin, Huiming Li, Suofu Qin
Safety, Tolerability, and Pharmacokinetics of Nebulized GB05-Human IFNα1b Inhalation Solution: A Randomized, Placebo-Controlled, Dose-Escalation Phase I Study in Healthy Chinese Adult Volunteers. Infectious diseases and therapy 13 (9) (2024)
Ranjeet S Bhamber, Brian Sullivan, Léo Gorman, Winnie W Y Lee, Matthew B Avison, Andrew W Dowsey, Philip B Williams
A Bayesian Model Based on Local Phenotypic Resistance Data to Inform Empiric Antibiotic Escalation Decisions. Infectious diseases and therapy 13 (9) (2024)
Daniele Roberto Giacobbe, Laura Labate, Chiara Russo Artimagnella, Cristina Marelli, Alessio Signori, Vincenzo Di Pilato, Chiara Aldieri, Alessandra Bandera, Federica Briano, Bruno Cacopardo, Alessandra Calabresi, Federico Capra Marzani, Anna Carretta, Annamaria Cattelan, Luca Ceccarelli, Giovanni Cenderello, Silvia Corcione, Andrea Cortegiani, Rosario Cultrera, Francesco Giuseppe De Rosa, Valerio Del Bono, Filippo Del Puente, Chiara Fanelli, Fiorenza Fava, Daniela Francisci, Nicholas Geremia, Lucia Graziani, Andrea Lombardi, Angela Raffaella Losito, Ivana Maida, Andrea Marino, Maria Mazzitelli, Marco Merli, Roberta Monardo, Alessandra Mularoni, Chiara Oltolini, Carlo Pallotto, Emanuele Pontali, Francesca Raffaelli, Matteo Rinaldi, Marco Ripa, Teresa Antonia Santantonio, Francesco Saverio Serino, Michele Spinicci, Carlo Torti, Enrico Maria Trecarichi, Mario Tumbarello, Malgorzata Mikulska, Mauro Giacomini, Anna Marchese, Antonio Vena, Matteo Bassetti, null null
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study. Infectious diseases and therapy 13 (9) (2024)